Concepedia

Takako Furukawa

TF

Statistics

Publications

6

Citations

131

H-Index

6

Active since

1977

Affiliations

Astellas Pharma (Japan)(Current)

Takako Furukawa is an author at Astellas Pharma (Japan) specializing in pharmacology, pharmacy, and pharmacokinetics.

ORCID

Publications per year

1977–2015

6

Publications

6

The in vitro metabolism of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) by hepatic microsomal cytochrome P-450.

D Karashima, Y Hirokata, A Shigematsu et al. · Journal of Pharmacology and Experimental Therapeutics · 1977 · 38 citations

, , +12

Species differences in intestinal glucuronidation activities between humans, rats, dogs and monkeys

Takako Furukawa, Yoichi Naritomi, Kazuhiro Tetsuka et al. · Xenobiotica · 2013 · 31 citations

, , +17

Quantitative Prediction of Intestinal Glucuronidation of Drugs in Rats Using In Vitro Metabolic Clearance Data

Takako Furukawa, Fumihiro Nakamori, Kazuhiro Tetsuka et al. · Drug Metabolism and Pharmacokinetics · 2011 · 18 citations

, , +15

Transcriptomic Signatures of Auger Electron Radioimmunotherapy Using Nuclear Targeting <sup>111</sup> In-Trastuzumab for Potential Combination Therapies

Huizi Keiko Li, Yukie Morokoshi, Kazuhiro Daino et al. · Cancer Biotherapy and Radiopharmaceuticals · 2015 · 17 citations

, , +17

Quantitative Prediction of Human Intestinal Glucuronidation Effects on Intestinal Availability of UDP-Glucuronosyltransferase Substrates Using In Vitro Data

Fumihiro Nakamori, Yoichi Naritomi, Ken‐ichi Hosoya et al. · Drug Metabolism and Disposition · 2012 · 14 citations

, , +17

1–5 of 6